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Abstract: Using the RNA-dependent RNA polymerase (RdRp) from poliovirus (PV) as our model
system, we have shown that Lys-359 in motif-D functions as a general acid in the mechanism of
nucleotidyl transfer. A K359H (KH) RdRp derivative is slow and faithful relative to wild-type
enzyme. In the context of the KH virus, RdRp-coding sequence evolves, selecting for the following
substitutions: I331F (IF, motif-C) and P356S (PS, motif-D). We have evaluated IF-KH, PS-KH, and
IF-PS-KH viruses and enzymes. The speed and fidelity of each double mutant are equivalent.
Each exhibits a unique recombination phenotype, with IF-KH being competent for copy-choice
recombination and PS-KH being competent for forced-copy-choice recombination. Although the
IF-PS-KH RdRp exhibits biochemical properties within twofold of wild type, the virus is impaired
substantially for recombination in cells. We conclude that there are biochemical properties of the
RdRp in addition to speed and fidelity that determine the mechanism and efficiency of recombination.
The interwoven nature of speed, fidelity, the undefined property suggested here, and recombination
makes it impossible to attribute a single property of the RdRp to fitness. However, the derivatives
described here may permit elucidation of the importance of recombination on the fitness of the viral
population in a background of constant polymerase speed and fidelity.
Keywords: enterovirus; RNA-dependent RNA polymerase (RdRp); nucleotidyl transfer mechanism;
general acid; fidelity; recombination; copy-choice; forced-copy-choice
1. Introduction
In spite of the substantial resources that have been allocated by the World Health Organization,
the National Institute of Allergy and Infectious Diseases, the European Centre for Disease Prevention
and Control, and the Centers for Disease Control and Prevention to support prediction of emerging
viral pathogens [1], viral outbreaks over the past few decades have been caused by viruses for which
surveillance was not considered a priority. Rapid response to an outbreak caused by an unexpected
viral pathogen requires, minimally, the existence of broad-spectrum, antiviral therapeutics. Prevention
requires the availability of vaccines, development of which could take years. Indeed, approved vaccines
still do not exist to prevent infections by West Nile virus or severe acute respiratory syndrome (SARS)
coronavirus, and these outbreaks occurred more than one decade ago.
Because all RNA viruses encode an RNA-dependent RNA polymerase (RdRp) with conserved
function and mechanism, this enzyme has emerged as an attractive target for development of
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broad-spectrum therapeutics [2–4] and a target for function/mechanism-based strategies for viral
attenuation [5–10]. One function/mechanism of the RdRp that has been targeted most is that required
for faithful incorporation of nucleotides [5–10]. Changing RdRp fidelity decreases or increases the
genetic variation of the viral population, which, in turn, decreases fitness and virulence of the viral
population [11–16].
Known RdRp variants exhibiting a high-fidelity phenotype can also exhibit a reduced speed of
nucleotide incorporation, at least at the biochemical level [17]. Replication speed is also a determinant
of viral fitness and virulence [18]. So, is it the increased fidelity or decreased speed of nucleotide
addition that gives rise to the attenuated phenotype? Further complicating the fidelity-versus-speed
question are the recent observations that changes to fidelity also have consequence for the efficiency
of recombination [19–24]. Increased RdRp fidelity decreases recombination efficiency and vice
versa [19–24]. It will likely be impossible to attribute a single biochemical property of the RdRp to
biological outcome.
The most extensively studied PV fidelity mutants encode RdRps with amino acid substitutions
at sites remote from the active site. Constructing equivalent substitutions conferring equivalent
phenotypes in RdRps other than PV is difficult if not impossible. Our laboratory has therefore pursued
active-site-based strategies to manipulate the fidelity, speed, and/or recombination efficiency of the
RdRp [25]. We have shown that a lysine (Lys-359 in PV) present in conserved structural motif D of the
RdRp contributes to the efficiency of nucleotidyl transfer [25]. A PV mutant encoding a K359R RdRp is
attenuated but elicits a protective immune response in mice that is at least as robust as the immune
response elicited by the type 1 Sabin vaccine strain [7].
In this study, we characterize a second motif-D mutant of PV (K359H). Unlike the K359R
RdRp-encoding virus [7], K359H PV is genetically unstable and acquires mutations encoding two
second-site amino acid substitutions after a few passages in cell culture. Together, the two substitutions
restore all biochemical properties of the derivative to near wild-type levels. Individually, however,
we observe differences in the mechanism (copy-choice vs. forced-copy-choice) and efficiency of
recombination by each derivative, although each derivative exhibits equivalent speed and fidelity.
We conclude that biochemical properties in addition to speed and fidelity must exist and contribute
to both the mechanism and efficiency of recombination. The desire to attribute single, biochemical
properties of the viral RdRp to fitness, virulence, and pathogenesis may be futile.
2. Materials and Methods
2.1. Cells and Viruses
Adherent monolayers of HeLa and L929 fibroblasts were grown in DMEM/F-12 media. Media was
supplemented with 100 U/mL penicillin, 100 µg/mL streptomycin, and 10% heat inactivated (HI)-FBS.
All cells were passaged in the presence of trypsin-EDTA. Wild-type and recombinant PV viruses were
recovered after transfection of RNA produced in vitro (see below) from full-length cDNA or from the
CRE-REP assay parental partners [23]. PV type 1 (Mahoney) was used throughout this study (GenBank
accession number: V01149.1).
2.2. Plasmids, In Vitro Transcription, Cell Transfection, and Virus Quantification
All mutations were introduced into the pET26Ub-PV 3D [26] bacterial expression plasmids using
overlap extension PCR. The presence of the desired mutations and the absence of additional mutations
were verified by DNA sequencing. The expression plasmid encoding the various mutations was
digested and inserted into an intermediate plasmid, pUC18-BglII-EcoRI-3CD (referred as pUC-3CD
in [27], and then the fragment between BglII and ApaI was cloned into the subgenomic replicon,
pRLucRA, or viral cDNA, pMovRA, or PV1∆CRE. PV1∆CRE is a full-length PV type 1 (Mahoney)
cDNA bearing 8 synonymous substitutions in the oriI cis-acting replication element (CRE) located in
the 2C-coding region and was described previously [23]. In order to create a fluorescence-based assay
Genes 2019, 10, 968 3 of 16
for recombination in cells, we modified the PV1∆CRE acceptor RNA to include the coding sequence for
UnaG green fluorescent protein. Briefly, UnaG-encoding sequence [28] carrying a 3C protease cleavage
site at its carboxyl terminus was inserted between the IRES and the P1 region of the PV sequence.
Translation occurred from the natural poliovirus initiation codon. Proteolytic cleavage and release
of the fluorescent protein occurred by normal 3C protease activity. Plasmids encoding PV genomes
(full length or subgenomic) were linearized with ApaI. All linearized cDNAs were transcribed in vitro
using T7 RNA Polymerase and treated with 2U DNAse Turbo (Thermo Fisher, Waltham, MA, USA) to
remove residual DNA template. The RNA transcripts were purified using RNeasy Mini Kit (Qiagen,
Germantown, MD, USA) before spectrophotometric quantification. Purified RNA in RNase-free H2O
was transfected into either HeLa or L929 fibroblasts using TransMessenger (Qiagen, Germantown, MD,
USA). Virus yield was quantified by plaque assay. Briefly, cells and media were harvested at 2–3 days
post-transfection, subjected to three freeze-thaw cycles, and clarified. Supernatant was then used on
fresh HeLa cells in 6-well plates; virus infection was allowed to continue for 30 min. Media was then
removed, and cells were washed twice with PBS (pH 7.4) washes before a 0.8% (w/v) agarose-media
overlay was added. Cells were incubated for 2–3 days and then fixed and stained with crystal violet
for virus quantification.
2.3. Luciferase Assays
Subgenomic luciferase assays were performed as described previously [29].
2.4. Virus Sequencing
Viral RNA was extracted from clarified culture supernatant using a Qiagen RNAeasy Mini kit,
reverse transcribed using Superscript II reverse transcriptase (Invitrogen, Waltham, MA, USA) using
an oligo-dT primer according to the manufacturer’s protocol. PCR amplification of the 3Dpol region
in PV used template cDNA and appropriate oligonucleotides as listed in Table 1 by using Phusion
high-fidelity DNA polymerase (NEB, Ipswich, MA, USA) according to the manufacturer’s protocol.
PCR products were gel purified and sequenced by the Genomics Core Facility of the Pennsylvania
State University.
Table 1. Oligonucleotides used in the study.
Oligonucleotide Sequence (5′-3′)
3D EcoRI-R AAT TAA TTC ATC GAT GAA TTC GGG CC
3D BglII-F GGC AAA GAA GTG GAG ATC TTG GAT GC
2.5. One-Step Growth Analysis
HeLa cells in 12-well plates were infected by each virus at a MOI of 10. Following a 30-minute
incubation, cells were washed twice with PBS and media was replaced. Virus was harvested at different
time-points post infection and the virus yield was quantified by plaque assay.
2.6. Quantitative RT-PCR
Viral RNA was purified from virus stocks by using QiaAmp viral RNA purification kit
(Qiagen, Germantown, MD, USA) and used for RT-qPCR to determine genome copies. This
analysis was performed by the Genomics Core Facility of the Pennsylvania State University.
DNAse- treated RNA was reverse-transcribed using the High Capacity cDNA Reverse Transcription
kit (Applied Biosystems, Foster City, CA, USA) following the protocol provided with the
kit. Quantification by real-time qPCR was done with 2X TaqMan Universal PCR Master
Mix (Applied Biosystems, Foster City, CA, USA) in a volume of 20 µL, with primers 5′-
ACCCCTGGTAGCAATCAATATCTTAC-3′ (forward) and 5′- TTCTTTACTTCACCGGGTATGTCA-3′
(reverse), and probe 5′-[6-Fam] TGTGCGCTGCCTGAATTTGATGTGA-3′ in a 7300 Real-Time
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qPCR System (Foster City, CA, USA) machine. A standard curve was generated using in vitro
transcribed RNA.
2.7. Ribavirin-Sensitivity Assay
This assay was described previously [30]. HeLa cells were treated with 600 µM ribavirin for
1 h before infection. Ribavirin-treated cells were then infected at MOI 0.1 with each virus variant.
Following infection, the cells were washed with PBS and media was replaced with ribavirin. Infection
was allowed for 24 h. Cells and supernatant were subjected to three freeze–thaw cycles. Media was
clarified and used for plaque assays. All yields were normalized to an untreated control.
2.8. Cell-Based Recombination Assay
This assay was developed in the laboratory of David Evans and was used as described
previously [23,31]. L929 fibroblasts were transfected with the PV donor and accepter RNAs, both
carrying the same mutations in the RdRp gene. For the fluorescence-based detection of recombinants,
the UnaG green fluorescence reporter was encoded by the acceptor RNA. Supernatant at 2–3 days
post-transfection was used to infect HeLa cells. Recombinant viruses were either quantified by plaque
assay or by fluorescence imaging (488 nm (ex) and 509 nm (em)).
2.9. Polymerase Expression and Purification
Purified polymerases used for biochemical analysis were prepared as described previously [26,27].
2.10. Poly(rU) Polymerase Activity Assay
Reactions contained 50 mM HEPES, pH 7.5, 10 mM 2-mercaptoethanol, 5 mM MgCl2, 60 µM
ZnCl2, dT15 (2 µM), poly(rA) (100 µM AMP), UTP (500 µM), α-32P-UTP (0.2 µCi/µL), and PV RdRp
(0.2 µM). Reactions were initiated by addition of PV RdRp and incubated at 30 ◦C for 5 min at which
time the reactions were quenched by addition of EDTA to a final concentration of 50 mM. Reaction
volumes were 50 µL. Products were analyzed by DE81 filter binding, where 10 µL of the quenched
reaction was spotted onto DE81 filter paper discs and dried completely. The discs were washed three
times for 10 min in 250 mL of 5% dibasic sodium phosphate and rinsed in absolute ethanol. Bound
radioactivity was quantitated by liquid scintillation counting in 5 mL of Ecoscint scintillation fluid
(National Diagnostics, Atlanta, GA, USA).
2.11. Sym/Sub-Based Template Switching Assay
The sym/sub assay has been described previously [23,32]. Elongation complexes were assembled
by incubating 5 µM PV RdRp with 1 µM sym/sub RNA primer-template and 500 µM ATP for 5 min
(Mix 1). Template-switching reactions were initiated by addition of 60 µM RNA acceptor template and
500 µM CTP, GTP, and UTP (Mix 2) and then quenched at various times by addition of 50 mM EDTA.
All reactions were performed at 30 ◦C in 50 mM HEPES, pH 7.5, 10 mM 2-mercaptoethanol, 60 µM
ZnCl2, and 5 mM MgCl2. Products were analyzed by denaturing polyacrylamide gel electrophoresis,
visualized using a PhosphorImager, and the transfer products quantified using ImageQuant TL
software (GE Healthcare, Chicago, IL, USA).
3. Results
3.1. K359H PV Requires Two Second-Site Substitutions to Restore a “Wild-Type” Growth Phenotype
Most studies of RdRp fidelity have benefited from the selection of derivatives that were either
more or less sensitive to a mutagenic nucleoside [33–38]. Almost invariably, the derivatives changed
residues remote from the catalytic site, thus using an allosteric mechanism to perturb fidelity. Among
the most famous of these is the G64S substitution in PV RdRp [16,17,34]. Many years ago, our laboratory
showed that the active site of all polymerases contain a general acid, Lys-359 in the case of PV RdRp,
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that protonated the pyrophosphate leaving group during nucleotidyl transfer, thereby increasing
the catalytic efficiency of RdRp [25]. Substitutions of Lys-359 in PV RdRp give rise to changes in
fidelity [7,18]. The arginine substitution of Lys-359 (K359R RdRp) and the histidine substitution (K359H
RdRp) catalyze nucleotidyl transfer at a rate 10-fold lower than wild type [25]. The impact of the
arginine substitution of Lys-359 on PV fidelity and its potential application to vaccine development
have been described [7].
Biological studies of K359H PV were not reported, because this virus was not genetically stable.
When PV is rescued from in vitro transcribed RNA, four passages are required for the genetic diversity
of the viral population to come to equilibrium [11]. During this time for K359H PV, mutations were
observed in RdRp-coding sequence that changed the plaque phenotype of the virus. One change
was in motif C, I331F, and the other change was in motif D, P356S (Figure 1A,B). We have adopted
the following nomenclature to refer to the various mutant PVs and their corresponding RdRps:
I331F-K359H, IF-KH; P356S-K359H, PS-KH; and I331F-P356S-K359H, IF-PS-KH. In order to compare
the impact of these substitutions on PV genome replication without complication of reversion, we
engineered the various substitutions into a subgenomic replicon, where the capsid coding P1 region
was replaced with the gene for firefly luciferase, producing luciferase as an indirect measure of viral
RNA produced [39–41]. Experiments in the presence of guanidine hydrochloride (GuHCl) report on
translation of transfected RNA in the absence of replication (Figure 1C). Relative to WT PV, K359H was
the most debilitated, with replication failing to reach an end point at 10 h post-transfection (Figure 1C).
Each double mutant was markedly better than K359H alone, but the addition of I331F conferred a
greater replication advantage than P356S (Figure 1C). The triple mutant replicated even faster but still
exhibited a significant reduction in the rate of replication relative to WT (Figure 1C).
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3.2. Characterization of the Double- and Triple-Mutant Viruses and Their Polymerases 
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Figure 1. Serial passage of K359H PV in cell culture leads to additional changes to RdRp-coding
sequence. (A) Changes in RdRp-coding sequence after serial passage of K359H PV. RNA was isolated
from passage 2, converted to cDNA, and amplified by PCR. The electropherogram of the sequenced PCR
product is shown, revealing two amino acid changes: I331F (motif C) and P356S (motif D). (B) Location
of I331, P356, and K359 in structure of PV RdRp. Palm, fingers, and thumb subdomains are shown.
Conserved structural motifs are colored: A, red; B, green; C, yellow; D, blue; E, purple; F, orange; G,
black. (C) Replication phenotypes observed for K359H PV and KH-containing PV mutants by using a
replicon assay. Replication was monitored using a subgenomic replicon firefly luciferase. Luciferase
specific activity is reported in relative light units (RLU) per microgram of total protein in the extract as
a function of time post-transfection. Shown is one representative data set. This experiment has been
repeated more than three times with similar results.
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3.2. Characterization of the Double- and Triple-Mutant Viruses and Their Polymerases
At multiplicities of infection of one or higher, the double- and triple-mutant viruses were stable
for multiple passages, thus permitting us to characterize the biological properties of these viruses.
Interestingly, the growth properties of the viruses were not as expected based on the experiments
with the replicon. Each mutant virus exhibited the same delay relative to WT virus prior to the first
detection of infectious virus after four hours post-infection (hpi) (Figure 2A). Thereafter, growth of each
virus was far more distinct than observed for the replicon, with PS-KH PV much slower than IF-KH
PV and IF-PS-KH PV was substantially faster than both double mutants (Figure 2A). The differences
in outcome could reflect the differences in replication efficiency and/or a direct consequence of the
substitutions in 3D-coding sequence on virus assembly or spread caused by changes to 3CD protein or
3D-containing precursor protein [29,42]. After a productive infection, the exponential phase of genome
replication by PV typically occurs between 2 and 6 h post-infection, with virus assembly occurring
between 4 and 8 h post-infection. Release of infectious virus by lytic and/or non-lytic mechanisms can
occur once virus is assembled and can persist for longer than 24 hours.
Our studies of RdRp fidelity mutants in cell culture have highlighted the fact that the use of
the plaque-forming unit (PFU) as a measure of virus concentration will mask changes in the specific
infectivity of the viral RNA [11]. As a result, our experiments generally use genomes instead of PFU as
the unit of measure [11]. In doing so, we can use genomes/PFU as a measure of the specific infectivity.
The instability of KH PV precluded rigorous, quantitative analysis of this virus, but at least 10-fold more
KH PV than WT PV was required to observe a comparable number of plaques. Both substitutions were
able to increase the efficiency of plaque formation relative to KH PV (Figure 2B). Indeed, the specific
infectivity of IF-KH PV was equivalent to WT. The addition of PS to IF-KH reduced the efficiency of
plaque formation; the specific infectivity of IF-PS-KH PV was reduced by twofold relative to IF-KH
PV (Figure 2B). Therefore, the behavior of PS-KH PV in the PFU-based growth assay relative to the
replicon assay likely reflects an additional defect to virus assembly and/or spread.
A change to the specific infectivity of the viral RNA caused by increased mutational load—that
is, reduced fidelity of the PS-KH RdRp, would also explain the observed reduction in the specific
infectivity of PS-KH PV relative to the other mutant PVs. To test this possibility, we evaluated the
sensitivity of each virus population to growth in the presence of ribavirin. We reasoned that the
mutagenic activity of ribavirin would exhibit the greatest negative impact on viruses with a mutator
phenotype as described previously [11]. Relative to WT, K359H PV exhibited the highest fidelity based
on the 2-log difference in sensitivity to ribavirin (Figure 2C). IF-KH and PS-KH PVs also exhibited a
higher fidelity than WT PV (Figure 2C). Importantly, both mutants exhibited essentially equivalent
fidelity phenotypes (Figure 2C), consistent with the suggestion above that the reduced efficiency of
plaque formation observed for PS-KH PV is likely related to impairment of virus assembly and/or
spread. Finally, evaluation of IF-PS-KH PV revealed equivalent sensitivity of this mutant to ribavirin
as observed for WT PV (Figure 2C), suggesting that fidelity had been returned to normal.
We have previously reported biochemical properties of the RdRps for the repertoire of mutant
viruses described above [18]. Consistent with these reports, each substitution increases the speed and
reduces the fidelity to create a biochemical phenotype on par with that observed for WT (Figure 2D).
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Virus was isolated 24 h post-infecti f r qRT-PCR to determine genomes/mL or plaque
assay to determine pfu/mL, with the quotient yielding specific infectivity, genomes/pfu. Two biological
replicates performed in triplicate for qPCR analysis. Statistical analyses were performed using unpaired,
two-tailed t-test (* significance level p ≤ 0.05, n.s. = non-significa t). (C) Ribavirin sensitivity. HeLa cells
were infected at a MOI 0.1 with each PV in the presence of 600 µM ribavirin. After a 24-h incubation
at 37 ◦C, virus was isolated and used for plaque assay. Indicated is the titer of virus recovered in the
presence of ribavirin normalized to that recovered in the absence of ribavirin. Solid bar indicates the
mean of each virus yield. Error bars indicate SEM (n = 3). Statistical analyses were performed using
unpaired, two-tailed t-test (** significance level p ≤ 0.005, n.s. = non-significant). (D) Biochemical
analysis. The rate constant for incorporation of a single correct nucleotide, ATP, (kpol,corr) and a single
incorrect nucleotide, GTP, (kpol,incorr) by each PV RdRp was performed as previously described [18].
Data are reported using one significant figure. The error reported is the standard error from the fit of
the data to a single exponential [18].
3.3. Biochemical Properties of the d p ther Than Speed and Fidelity Contribute to the Efficiency of
Recombination in Cell Culture
Based on the myri fidelity mutants that have been reported to dat , there ppears to
be a direct correlation between the rate of nucleotide addition (speed) and the fidelity of nucleotide
addition [7,11,18,23,43]. This correlation also extends to recombination efficiency [23]. If this is the case,
then the ongoing debate of speed versus fidelity as the key determinant of viral fitness will become
even more complicated to resolve [18].
The current state of the art for evaluation of recombination in cell culture is based on the
co-transfection of two viral (sub) genomic RNAs incapable of producing infectious virus [31]. The donor
RNA is a replication-competent, subgenomic RNA that encodes a luciferase reporter instead of the
viral capsid (Figure 3A). The acceptor RNA is a replication-incompetent, genomic RNA that has a
defective cis-acting replication element, termed oriI (Figure 3A) [31]. Initiation of replication on the
donor followed by a switch to the acceptor at a site after the oriI locus will yield an infectious genome
that can be scored by plaque assay (Figure 3A) [31].
We evaluated our panel of KH-containing PV mutants using this assay, and the outcomes were,
in most cases, quite unexpected (Figure 3B). KH PV was unable to produce viable recombinants,
as expected for a high-fidelity RdRp [23]. The first surprise was that IF-KH and PS-KH PVs did
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not exhibit the same phenotypes (Figure 3B). While IF-KH PV produced viable recombinant virus,
PS-KH PV did not (Figure 3B). Based on the experiments performed above, these viruses and their
polymerases replicate with comparable efficiency and fidelity (Figures 1A and 2C,D). Even more
surprising, however, was the observation that IF-PS-KH PV was impaired more than one log relative to
WT PV in its ability to produce viable recombinants (Figure 3B). The replication efficiency and fidelity
of this virus and its polymerase were always within twofold of that observed for WT (Figures 1A
and 2C,D). Together, these results suggest that there are properties of the PV RdRp important for
recombination that are not revealed by our existing biological and biochemical assays.
The one caveat of the recombination assay is that the recombinant viruses produced must be able
to form plaques, which may mean that the recombinant virus must spread by a lytic mechanism. It was
possible that PS-KH PV was defective for virus assembly and/or spread, at least lytic spread (Figure 2B).
In order to score for recombinant viruses that spread by either a lytic or non-lytic mechanism, we
engineered the acceptor template to encode the UnaG [28] green fluorescent protein (Figure 3C). The
polyprotein was designed such that UnaG protein is released from capsid precursor protein by 3C
protease activity. Observation of green cells were visible from a donor-acceptor pair producing WT
RdRp as early as 7 hpi, with increases continuing over a 48-h period (Figure 3D). With the sensitivity
of this assay and the absence of a requirement for lytic spread, it is clear that PS-KH PV exhibits a
recombination defect (Figure 3D).
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(A) Schematic of the PV recombinatio [ ]. T o RNAs are used: a replication-competent
subgenomic RNA l i capsid-coding sequence (donor RNA); and a replicati n-incompetent
fu l-length genomic RNA with a defective is-acting replication element (CRE, indicated by hairpin
with defecti versio indicated by X) in 2C-coding sequence (acceptor RNA). Co-transfecti n of these
RNAs produces infectious virus if reco i s. (B) The indicated PV RdRp was engin ered
into both donor and ac epter RNA an i to a L929 mouse fibroblast cell line. Infectious
virus produced by recombination i L92 cells was determined by plaque ass y using HeLa cells. Each
point shown is an independent experiment reflecting the average of three replicates. When plaques
could not be detected, n.d. is indicated. Mean and SEM (n = 5) are indicated. Statistical analyses were
performed using unpaired, two-tailed t-test (* significance level p ≤ 0.05). (C) Schematic of a modified
PV recombination assay using an acceptor RNA expressing the green fluorescent protein, UnaG [28].
Recombinants are scored by expression of green fluorescence instead of plaques, thereby increasing the
sensitivity. (D) Infectious virus produced by recombination in L929 was scored for infectious virus in
HeLa cells 7, 24, and 48 h post-infection for WT and at 48 h only for K359H and PS-KH. Shown is one
representative image from three independent experiments.
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3.4. Poly(rU) Polymerase Activity as a Predictor of the Efficiency of Copy-Choice Recombination in Cell Culture
Twenty years ago, we showed that template switching was the primary mechanism of product
formation when oligo (dT) or oligo(rU) were used to prime poly(rU) RNA synthesis on oligo(rA) or
poly(rA) RNA templates [32]. Briefly, polymerase engages a primed template, elongates that primer,
disengages from the first template at some point during the elongation process to engage a second
(acceptor) template and continue RNA synthesis (Figure 4A) [32]. This process occurs reiteratively,
yielding products that are much greater than the average length of template used in the reaction [32].
The observation that only a subset of the KH mutants were competent for recombination,
presumably by a copy-choice mechanism [44], provided the opportunity to determine the extent to
which the poly (rU) polymerase activity can predict biological phenotypes. The congruence between
the two experiments was remarkable (Figure 4B). Both KH and PS-KH RdRps were impaired for
poly (rU) polymerase activity, both IF-KH and IF-PS-KH RdRps exhibited near-WT levels of poly
(rU) polymerase activity (Figure 4B). These results further confirm template switching as the primary
mechanism of poly (rU) polymerase activity and validate this assay as a screen for identification of
RdRps with deficits in template switching.
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Figure 4. RdRp derivatives incapable of recombination in cells exhibit defects in copy-choice
recombination (template switching) in vitro. (A) Products of reactions using oligo/poly(rA) as template
reflect copy-choice recombination, which requires the template-switching activity of the RdRp [32].
RdRp engages primed template and initiates RNA synthesis. The RdRp-nascent RNA complex moves to
new template from internal positions or as a consequence of reaching the end of template, thus creating
greater-than-template-length products. (B) Specific poly (rU) polymerase activity (pmol/min/µg) of
each RdRp. WT and the indicated PV RdRp variants assessed by using a poly (rU) polymerase activity
assay. Error bars represent SEM (n = 3). Statistical analyses were performed using unpaired, two-tailed
t-test (** significance level p ≤ 0.01, n.s. = non-significant).
3.5. Polymerase Determinants Supporting Efficient Copy-Choice Recombination do not Overlap Completely
With Determinants Supporting Efficient Forced-Copy-Choice Recombination
Recently, our laboratory developed an assay for forced-copy-choice recombination [23,45], inspired
by an analogous assay developed to study template switching by the reverse transcriptase from human
immunodeficiency virus [46–48]. The concept of the assay and templates used are presented in
Figure 5A. The experimental design is diagrammed in Figure 5B. Polymerase assembles on the primed
template (sym/sub-U). In the presence of only the first nucleotide (ATP), the assembled complexes can
be identified as the one-nucleotide-extended product (n + 1). Addition of the remaining nucleotides in
the absence or presence of the acceptor template will yield a strong-stop RNA product. In the presence
of a complementary acceptor RNA, the strong-strop RNA product (donor) will be extended, creating a
transfer product.
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We evaluated each KH-containing RdRp derivative in this assay. Substrate and product analysis
are presented in Figure 5C, with the quantitation of the transfer product relative to WT presented
in Figure 5D. KH RdRp was defective in this assay as well, as transfer product was not detected
(Figure 5C). Importantly, the failure to transfer was not a reflection of the inability to assemble or
produce strong-stop donor RNA (Figure 5C). In this assay, PS-KH RdRp outperformed IF-KH RdRp,
and PS-KH and IF-PS-KH RdRp were essentially identical in activity.
We conclude that copy-choice and forced-copy-choice recombination use distinct mechanisms,
requiring unique biochemical properties of the RdRp.
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Figure 5. Properties of the RdRp required for copy-choice recombination in vitro are separable from
those required for forced-copy-choice recombination in vitro. (A) The heteropolymeric, symmetrical,
primed-template substrate (sym/sub) has been used to establish an assay for forced-copy-choice
recombination in vitro [23,45]. RdRp assembles on sym/sub. ATP is added and incorporated to yield a
stable elongation complex. It is this elongation complex that is monitored for extension and transfer.
Transfer is strictly dependent on the presence of an acceptor RNA with complementarity to the 3′-end
of donor RNA. (B) Schematic of the experimental design is indicated. Products in boxes are those
observed and monitored by denaturing polyacrylamide gel electrophoresis. (C) Reaction products
were resolved by electrophoresis and detected by phosphorimaging. The only regions of the gel with
bands are shown; these correspond to the sym/sub primer, one-nucleotide-extended primer (n+1),
four-nucleotides-extended product (strong stop) and non-templated addition of nucleotides to that
product, and the transfer product. (D) Transfer products were quantified and are expressed as a
percentage relative to the value observed for WT (The concentrations (µM) of n+1 formed for WT,
K359H, IF-KH, PS-KH and IF-PS-KH are 0.22, 0.22, 0.32, 0.36, and 0.37, respectively. The concentrations
(µM) of transfer product for WT, K359H, IF-KH, PS-KH, and IF-PS-KH are 0.011, 0.00011, 0.0016, 0.0072,
and 0.01, respectively. Overall, transfer efficiency ranges from 1% to 5%. Error bars represent SEM
(n = 3). Statistical analyses were performed using unpaired, two-tailed t-test (** significance level
p = 0.0001).
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4. Discussion
For more than a decade now, our laboratory and others have published studies asserting
connections between viral RdRp fidelity and viral fitness [11–16]. However, in the few instances in which
RdRp derivatives exhibiting perturbed fidelity have been characterized, these derivatives also exhibit
changes to the rate of nucleotide addition [7,11,18,23,43]. Relative to wild-type polymerase, a higher
fidelity polymerase is a slower enzyme, and a lower fidelity polymerase is a faster enzyme [7,11,18,23,43].
Polymerase speed will clearly determine replication kinetics and therefore can contribute to viral
fitness, as has been suggested recently [18]. The most extensively characterized fidelity mutants of PV
harbor an RdRp with a substitution located at a remote site that likely causes substantial collateral
damage, further confounding the fidelity-versus-speed debate [5,17]. This study was motivated by the
need to better understand the relationship between the biochemical properties of the viral RdRp and
viral fitness, virulence, and pathogenesis. We have had in hand for a long time a PV mutant whose
speed and fidelity were perturbed by changing an RdRp active-site residue, K359H [25]. We did not
publish this PV mutant until now because of its genetic instability (Figure 1A). We realized that this
genetic instability might actually represent an opportunity, as the biochemical phenotypes reverted by
the second-site suppressors might highlight the biochemical properties driving viral fitness.
Lys-359 protonates the pyrophosphate leaving group during nucleotidyl transfer [25,49]. The
K359H substitution will change the efficiency of that protonation event for two reasons. First, the pKa
value of histidine is substantially lower than lysine and will therefore not be protonated to the same
extent. Second, the distance between the nucleotide phosphates and the imidazole ring of the histidine
will be greater than that of the amino group of lysine. It is likely that the distance is more of an issue,
because K359R PV is stable and K359R RdRp exhibits the same reduction in catalytic efficiency as
K359H RdRp [7]. The changes of I331F and P356S in motifs C and D, respectively, may hypothetically
serve to move His-359 closer to the nucleotide phosphates.
Each substitution (IF and PS) individually increased the replication efficiency of K359H PV, with
the combination of the two substitutions producing an additive outcome (Figure 1C). Each substitution
also decreased the fidelity of nucleotide addition in cells, as assessed by ribavirin sensitivity, to the
same extent; the combination mutant yielded a virus with properties on par with wild type (Figure 2C).
The observed changes to replication speed and fidelity for the mutant viruses were explained by the
biochemical properties of the corresponding RdRps (Figure 2D). As observed in the past, both speed
and fidelity appear to be correlated.
The substitutions at the active site of the polymerase do not only affect replication efficiency and
population diversity but also impact other stages of the lifecycle. The kinetics of virus production for
the different mutants did not correspond directly to the kinetics of replication (compare Figure 2A
to Figure 1C). Virus production was significantly delayed for PS-KH PV (Figure 2A). This issue with
virus production manifests as a substantial decrease in the specific infectivity of this virus (Figure 2B).
One possible explanation for this outcome is that the RdRp is encoded by the 3D region of the viral
genome and this region is also a component of the PV 3CD protein. The 3CD protein has well
established roles in aspects of the lifecycle before, during, and after replication, including virion
morphogenesis [29,42,50,51]. Observations such as these highlight the additional level of complexity
associated with establishing a cause-and-effect relationship between biochemical properties of the
RdRp and fitness, virulence, and/or pathogenesis.
We and others have observed correlations between RdRp fidelity and recombination efficiency,
with higher fidelity suppressing recombination and vice versa [19–24]. An unexpected outcome of
this study was the observation that IF-KH and PS-KH PVs exhibit substantially different propensities
for recombination in cells (Figure 3B), in spite of very similar speed and fidelity phenotypes in cells
(Figures 1C and 2C) and in vitro (Figure 2D). PS-KH PV appeared to be completely incapable of
supporting recombination in cells (Figure 3B). Because the cell-based recombination assay requires
the ability of virus to plaque, it was conceivable that the defect of PS-KH PV was more a reflection
of virus spread than impaired recombination. We established a more sensitive fluorescence-based
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assay (Figure 3C), which also indicated impaired recombination (Figure 3D). The impact of the PS
substitution on recombination was also quite evident in the context of IF-PS-KH PV. The biological and
biochemical properties of this triple mutant are within twofold of wild type (Figures 1 and 2), but the
recombination efficiency of this mutant is down by 30-fold relative to WT PV (Figure 3B). Together,
these observations support the existence of biochemical properties of the RdRp other than speed
and fidelity that are essential for recombination and impaired by changing Pro-356 to Ser. Further
characterization of these mutants will be required to identify this undefined biochemical property.
Our laboratory has had a longstanding interest in the mechanism of recombination [19,20,23,32,45].
We have shown that the high poly (rU) polymerase activity of PV RdRp derives from template switching
during elongation, thus mimicking copy-choice recombination (Figure 4A) [32]. A second assay that we
developed is based on template switching from the end of template, thus mimicking forced-copy-choice
recombination (Figure 5A) [23,45]. Based on the mutants and corresponding RdRp derivatives reported
here, high fidelity impairs both types of recombination (see K359H in Figures 4B and 5D). Interestingly,
unique RdRp determinants exist for each mode of recombination. PS-KH RdRp is impaired for
copy-choice recombination (Figure 4B); IF-KH is impaired for forced-copy-choice recombination
(Figure 5D). Impairment of recombination by PS-KH PV in cells is consistent with template switching
as the primary mechanism of copy-choice recombination in cells, as demonstrated by Kirkegaard and
Baltimore [44]. The observation that IF-KH PV fails to exhibit a wild-type recombination phenotype
(Figure 3B) may suggest that forced-copy-choice recombination contributes to recombination in cells
as well.
The current narrative of the characterized PV mutants impaired for recombination is that
recombination acts as a mechanism to purge deleterious mutations in the viral population [52–54]. Our
study reveals several caveats for the interpretation of these previous studies. There are known and
unknown biochemical properties of the RdRp that determine recombination efficiency, and there are at
least two distinct mechanisms of recombination. Without understanding the biochemical properties
of the mutants under investigation, it is difficult to compare one study to another that may explain
disparate observations made between laboratories [30,55]. Further analysis of the panel of mutants
reported here may help to resolve the controversy but should illuminate how changes to the mechanism
and efficiency of recombination impact viral evolution in a background of constant speed and fidelity.
Viral fitness, virulence, and pathogenesis are determined collectively by the structure, dynamics,
and activity of all virus-encoded functions. The conserved structure, dynamics, and mechanism of the
viral RdRp makes this enzyme an attractive target for development of attenuated viruses by changing
conserved residues capable of perturbing conserved, biochemical function [7,9,11]. As a field, we
have focused on RdRp fidelity [7] but have come to the realization that RdRp speed should not be
ignored [18]. This study shows that speed, fidelity, and undefined biochemical properties of the
RdRp exist and contribute to both the mechanism and efficiency of recombination (Figure 6). This
inextricable connection of the myriad biochemical properties of the RdRp precludes attribution of a
single biochemical property to viral fitness, virulence, and pathogenesis (Figure 6). The field will be
served best by continued emphasis on discovery of manipulatable functions of the RdRp, and other
viral enzymes, instead of debating the importance of individual properties.
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